Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-29

Clinical Trial Update: Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing vonoprazan to lansoprazole in erosive esophagitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)
  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Phathom Pharmaceuticals, Inc. | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED | Results posted: 2022-07-29